dc.creator | Buitrago López, Adriana | |
dc.creator | Sanderson, Jean | |
dc.creator | Johnson, Laura | |
dc.creator | Warnakula, Samantha | |
dc.creator | Wood, Angela | |
dc.creator | Di Angelantonio, Emanuele | |
dc.creator | Franco, Oscar | |
dc.date.accessioned | 2022-09-22T15:42:08Z | |
dc.date.accessioned | 2022-09-27T12:44:39Z | |
dc.date.available | 2022-09-22T15:42:08Z | |
dc.date.available | 2022-09-27T12:44:39Z | |
dc.date.created | 2022-09-22T15:42:08Z | |
dc.date.issued | 2011 | |
dc.identifier | 0959- 8138 | |
dc.identifier | https://repositorio.fucsalud.edu.co/handle/001/3167 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/3596964 | |
dc.description.abstract | Abstract
Objective To evaluate the association of chocolate consumption with
the risk of developing cardiometabolic disorders.
Design Systematic review and meta-analysis of randomised controlled
trials and observational studies.
Data sources Medline, Embase, Cochrane Library, PubMed, CINAHL,
IPA, Web of Science, Scopus, Pascal, reference lists of relevant studies
to October 2010, and email contact with authors.
Study selection Randomised trials and cohort, case-control, and cross
sectional studies carried out in human adults, in which the association
between chocolate consumption and the risk of outcomes related to
cardiometabolic disorders were reported.
Data extraction Data were extracted by two independent investigators,
and a consensus was reached with the involvement of a third. The
primary outcome was cardiometabolic disorders, including cardiovascular
disease (coronary heart disease and stroke), diabetes, and metabolic
syndrome. A meta-analysis assessed the risk of developing
cardiometabolic disorders by comparing the highest and lowest level of
chocolate consumption.
Results From 4576 references seven studies met the inclusion criteria
(including 114 009 participants). None of the studies was a randomised
trial, six were cohort studies, and one a cross sectional study. Large
variation was observed between these seven studies for measurement
of chocolate consumption, methods, and outcomes evaluated. Five of
the seven studies reported a beneficial association between higher levels
of chocolate consumption and the risk of cardiometabolic disorders. The
highest levels of chocolate consumption were associated with a 37%
reduction in cardiovascular disease (relative risk 0.63 (95% confidence
interval 0.44 to 0.90)) and a 29% reduction in stroke compared with the
lowest levels.Conclusions Based on observational evidence, levels of chocolate
consumption seem to be associated with a substantial reduction in the
risk of cardiometabolic disorders. Further experimental studies are
required to confirm a potentially beneficial effect of chocolate
consumption | |
dc.language | eng | |
dc.publisher | BMJ Publishing Group Ltd. | |
dc.publisher | Reino Unido | |
dc.relation | 10 | |
dc.relation | d4488 | |
dc.relation | 343 | |
dc.relation | The BMJ, llamada British Medical Journa | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.rights | Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0) | |
dc.rights | https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.rights | http://purl.org/coar/access_right/c_abf2 | |
dc.source | https://www.bmj.com/content/343/bmj.d4488 | |
dc.title | Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis | |
dc.type | Artículo de revista | |